Clinical Trials
2 trialsNCT04454476 2024-07-31
Reversal of Preneoplastic Metaplasia in the Stomach With MEK Inhibitor
Vanderbilt-Ingram Cancer Center
Phase 1 Active not recruiting
NCT01013831 2015-02-18
Erlotinib Hydrochloride in Preventing Cancer in Patients With Precancerous Lesions of the Lung
National Cancer Institute (NCI)
Phase 1 Terminated